Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|3|1|69-75

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.3, Iss.1, 2009-01, pp. : 69-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signaling Pathways Associated with Inflammatory Bowel Disease

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 4, Iss. 2, 2010-06 ,pp. : 105-117

Bentham Science Publishers

Access to resources Recommend Favorite

Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD)

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 11, Iss. 1, 2017-08 ,pp. : 41-52

Bentham Science Publishers

Access to resources Recommend Favorite

Current Opinion on 3-[2-[(2-Tert-Butyl-Phenylaminooxalyl)-Amino]-Propionylamino]- 4-Oxo-5-(2,3,5,6-Tetrafluoro-Phenoxy)-Pentanoic Acid, an Investigational Drug Targeting Caspases and Caspase-Like Proteases: The Clinical Trials in Sight and Recent Anti-Inflammatory Advances

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 7, Iss. 3, 2013-09 ,pp. : 229-258

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on Mesenchymal Stem Cell Mediated Therapy in Inflammatory Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 7, Iss. 2, 2013-05 ,pp. : 105-113

Bentham Science Publishers

Access to resources Recommend Favorite

Associations between Periodontitis and Systemic Inflammatory Diseases: Response to Treatment

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 7, Iss. 3, 2013-09 ,pp. : 169-188

Bentham Science Publishers

Access to resources Recommend Favorite